| EAU guidelines on renal cell carcinoma: 2014 update B Ljungberg, K Bensalah, S Canfield, S Dabestani, F Hofmann, M Hora, ... European urology 67 (5), 913-924, 2015 | 3028 | 2015 |
| Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up B Escudier, C Porta, M Schmidinger, N Rioux-Leclercq, A Bex, V Khoo, ... Annals of Oncology 30 (5), 706-720, 2019 | 1620 | 2019 |
| European association of urology guidelines on renal cell carcinoma: the 2019 update B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah, S Dabestani, ... European urology 75 (5), 799-810, 2019 | 1348 | 2019 |
| Epidemiology of renal cell carcinoma U Capitanio, K Bensalah, A Bex, SA Boorjian, F Bray, J Coleman, JL Gore, ... European urology 75 (1), 74-84, 2019 | 1316 | 2019 |
| European Association of Urology guidelines on renal cell carcinoma: the 2022 update B Ljungberg, L Albiges, Y Abu-Ghanem, J Bedke, U Capitanio, ... European urology 82 (4), 399-410, 2022 | 754 | 2022 |
| Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ... European urology 69 (4), 660-673, 2016 | 584 | 2016 |
| Guidelines on renal cell carcinoma B Ljungberg, K Bensalah, A Bex, S Canfield, S Dabestani, F Hofmann, ... European association of urology 14, 2015 | 494 | 2015 |
| Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical … A Bex, P Mulders, M Jewett, J Wagstaff, JV Van Thienen, CU Blank, ... JAMA oncology 5 (2), 164-170, 2019 | 453 | 2019 |
| Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions JA Nieuwenhuijzen, RR de Vries, A Bex, HG van der Poel, W Meinhardt, ... European urology 53 (4), 834-844, 2008 | 375 | 2008 |
| Local treatments for metastases of renal cell carcinoma: a systematic review S Dabestani, L Marconi, F Hofmann, F Stewart, TBL Lam, SE Canfield, ... The Lancet Oncology 15 (12), e549-e561, 2014 | 344 | 2014 |
| European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology guidelines … MJ Ribal, P Cornford, A Briganti, T Knoll, S Gravas, M Babjuk, C Harding, ... European urology 78 (1), 21-28, 2020 | 274 | 2020 |
| Tumour-specific proline vulnerability uncovered by differential ribosome codon reading F Loayza-Puch, K Rooijers, LCM Buil, J Zijlstra, J F. Oude Vrielink, ... Nature 530 (7591), 490-494, 2016 | 248 | 2016 |
| Male‐to‐female transsexualism: A technique, results and long‐term follow‐up in 66 patients S Krege, A Bex, G Lümmen, H Rübben BJU international 88 (4), 396-402, 2001 | 238 | 2001 |
| Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues D Hameyer, A Loonstra, L Eshkind, S Schmitt, C Antunes, A Groen, ... Physiological genomics 31 (1), 32-41, 2007 | 223 | 2007 |
| Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: current paradigms, use of immunotherapy, and future directions AKA Lalani, BA McGregor, L Albiges, TK Choueiri, R Motzer, T Powles, ... European urology 75 (1), 100-110, 2019 | 218 | 2019 |
| Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell … L Albiges, T Powles, M Staehler, K Bensalah, RH Giles, M Hora, ... European urology 76 (2), 151-156, 2019 | 210 | 2019 |
| Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer T Powles, L Albiges, M Staehler, K Bensalah, S Dabestani, RH Giles, ... European urology 73 (3), 311-315, 2018 | 206 | 2018 |
| Critical appraisal of the PADUA classification and assessment of the RENAL nephrometry score in patients undergoing partial nephrectomy MN Hew, B Baseskioglu, K Barwari, PH Axwijk, C Can, S Horenblas, ... The Journal of urology 186 (1), 42-46, 2011 | 203 | 2011 |
| Sunitinib for treatment of advanced renal cell cancer: primary tumor response AAM Van der Veldt, MR Meijerink, AJM van den Eertwegh, A Bex, ... Clinical Cancer Research 14 (8), 2431-2436, 2008 | 198 | 2008 |
| Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma XD Liu, A Hoang, L Zhou, S Kalra, A Yetil, M Sun, Z Ding, X Zhang, S Bai, ... Cancer immunology research 3 (9), 1017-1029, 2015 | 192 | 2015 |
Prof. Dr. med. Axel S. MerseburgerUniversität Lübeck在 uksh.de 的电子邮件经过验证
Prof. Dr. med. Axel S. MerseburgerUniversität Lübeck在 uksh.de 的电子邮件经过验证
Grant D StewartProfessor of Surgical Oncology, University of Cambridge在 cam.ac.uk 的电子邮件经过验证